BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9678812)

  • 1. Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate.
    Ricciardiello L; Cannizzaro O; D'Angelo A; Ederle A; Gerace G; Iaquinto G; Reina G; Scarpulla G; Spadaccini A; Olivieri A; Tosatto R; Fossi S; Pozzato P; Zagari M; Bazzoli F; Roda E
    Aliment Pharmacol Ther; 1998 Jun; 12(6):533-7. PubMed ID: 9678812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection.
    Cammarota G; Cannizzaro O; Ojetti V; Cianci R; Pastorelli A; Armuzzi A; Gentiloni N; Gasbarrini A; Pirozzi G; Gasbarrini G
    Aliment Pharmacol Ther; 2000 Jan; 14(1):73-7. PubMed ID: 10632648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin.
    Cammarota G; Cannizzaro O; Tursi A; Papa A; Gasbarrini A; Cuoco L; Cianei R; Armuzzi A; Fedeli P; Fedeli G; Gasbarrini G
    Aliment Pharmacol Ther; 1998 Jun; 12(6):539-43. PubMed ID: 9678813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection. H. Pylori Lombardy Group.
    Cestari R
    Aliment Pharmacol Ther; 1998 Oct; 12(10):991-6. PubMed ID: 9798804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer.
    Pozzato P; Zagari M; Cardelli A; Catalano FA; Giglio A; Lami F; Pilotto A; Scarpulla G; Spadaccini A; Susi D; Tosatto R; Olivieri A; Bazzoli F; Roda E
    Aliment Pharmacol Ther; 1998 May; 12(5):447-51. PubMed ID: 9663724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
    Bardhan KD; Morton D; Perry MJ; Sanders DS; Morris P; Rowland A; Thompson M; Mitchell TR; Roberts PM
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1199-204. PubMed ID: 11472323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
    de Boer WA; Haeck PW; Otten MH; Mulder CJ
    Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
    Sung JJ; Chan FK; Wu JC; Leung WK; Suen R; Ling TK; Lee YT; Cheng AF; Chung SC
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1079-84. PubMed ID: 10468684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
    Luzza F; Giglio A; Ciliberto E; Belmonte A; Cavaliere C; Saccà N; Frandina C; Fiocca R; Trimboli V; Pallone F
    Clin Ther; 2001 May; 23(5):761-70. PubMed ID: 11394734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection.
    Cammarota G; Cannizzaro O; Cianci R; Gasbarrini A; Pirozzi G; Gasbarrini G
    Hepatogastroenterology; 2000; 47(34):1176-9. PubMed ID: 11020908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori.
    Veldhuyzen van Zanten S; Chiba N; Barkun A; Fallone C; Farley A; Cockeram A; Dallaire C; Simms L; Nicholls B
    Can J Gastroenterol; 2003 Sep; 17(9):533-8. PubMed ID: 14532926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer.
    Sung JJ; Leung WK; Ling TK; Yung MY; Chan FK; Lee YT; Cheng AF; Chung SC
    Aliment Pharmacol Ther; 1998 Aug; 12(8):725-30. PubMed ID: 9726384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.
    Lu H; Zhang DZ; Hu PJ; Li ZS; Lu XH; Fang XC; Xiao SD
    Aliment Pharmacol Ther; 2001 Dec; 15(12):1975-9. PubMed ID: 11736729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
    Spadaccini A; De Fanis C; Sciampa G; Russo L; Silla M; Pantaleone U; Di Virgilio M; Pizzicanella G
    Aliment Pharmacol Ther; 1998 Oct; 12(10):997-1001. PubMed ID: 9798805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer.
    Catalano F; Catanzaro R; Bentivegna C; Brogna A; Condorelli G; Cipolla R
    Aliment Pharmacol Ther; 1998 Jan; 12(1):59-62. PubMed ID: 9692702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
    Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
    Aliment Pharmacol Ther; 2000 Sep; 14(9):1141-50. PubMed ID: 10971230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor efficacy of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori eradication.
    Uygun A; Kadayifci A; Yesilova Z; Ates Y; Safali M; Ilgan S; Bagci S; Dagalp K
    Indian J Gastroenterol; 2007; 26(4):174-7. PubMed ID: 17986746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.